Le Lézard
Classified in: Health
Subjects: TDS, CSR

ASGE Launches Public Service Awareness Campaign to Preempt Esophageal Cancer


DOWNERS GROVE, Ill., June 4, 2018 /PRNewswire/ -- The American Society for Gastrointestinal Endoscopy (ASGE) today launched a campaign to inform the public about the link between chronic heartburn and esophageal adenocarcinoma, one of the fastest growing cancers in the US, and that due to recent advances in the detection and treatment of precancerous cells, gastroenterologists (GI's) are now better equipped to help prevent this cancer before it can even start.

The airport focused campaign, which is being launched in conjunction with Digestive Disease Week (DDW), the preeminent annual gastroenterology meeting (GI) taking place this week in Washington DC, will feature advertisements in the Dulles and Reagan National airports, as well as on Amtrak Acela trains ? sending the public to www.asge.org/heartburn.

"We hope that our PSA campaign will encourage more Americans with chronic heartburn to see a gastroenterologist and take advantage of our recently enhanced ability to prevent one of the most rapidly growing cancers in the US," said ASGE President Karen L. Woods, MD, FASGE.

Interested DDW attendees can obtain materials at the ASGE booth (#1733) during DDW June 2-5, 2018 at the Walter E. Washington Convention Center, Washington, DC. The PSA campaign is funded through a partnership with CDx Diagnostics, the provider of WATS3D testing for precancerous cells.

For more information visit www.asge.org/heartburn.

About Gastrointestinal Endoscopy 
Gastrointestinal endoscopic procedures allow the gastroenterologist to visually inspect the upper gastrointestinal tract (esophagus, stomach and duodenum) and the lower bowel (colon and rectum) through an endoscope, a thin, flexible device with a lighted end and a powerful lens system. Endoscopy has been a major advance in the treatment of gastrointestinal diseases. For example, the use of endoscopes allows the detection of ulcers, cancers, polyps and sites of internal bleeding. Through endoscopy, tissue samples (biopsies) may be obtained, areas of blockage can be opened and active bleeding can be stopped. Polyps in the colon can be removed, which has been shown to prevent colon cancer.

About the American Society for Gastrointestinal Endoscopy 
Since its founding in 1941, the American Society for Gastrointestinal Endoscopy (ASGE) has been dedicated to advancing patient care and digestive health by promoting excellence and innovation in gastrointestinal endoscopy. ASGE, with more than 15,000 members worldwide, promotes the highest standards for endoscopic training and practice, fosters endoscopic research, recognizes distinguished contributions to endoscopy, and is the foremost resource for endoscopic education. Visit www.asge.org and www.screen4coloncancer.org for more information and to find a qualified doctor in your area.

Contact:
Erich Sandoval
Lazar Partners Ltd. 
Tel: +1 917-497-2867
Email: [email protected]

 

SOURCE American Society for Gastrointestinal Endoscopy


These press releases may also interest you

at 23:00
GenScript, a global leader in life sciences and biotechnology, successfully hosted an Open Day event at its Singapore facility on the 16th of April, welcoming more than 50 representatives from Singapore. This event provided an exclusive look into...

at 23:00
Cybervation, an award-winning global technology and healthcare solutions company, proudly announces that its CEO, Purba Majumder, has been distinguished as one of the 2024 100 Women to KNOW Across America. This award from KNOW Women recognizes...

at 22:33
The report titled "Glycated Albumin Assay Market by Product (Animal Glycated Albumin Assay, Human Glycated Albumin Assay), Application (Prediabetes, Type 1 Diabetes, Type 2 Diabetes), End User - Global Forecast 2024-2030" is now available on...

at 22:03
The report titled "Health & Wellness Food Market by Type (Fresh & Natural, Functional Foods & Beverages, Heat & Eat), Nature (Genetically Modified Organism Food, Non-Genetically Modified Organism Food), Fat Content, Category, Free From Category,...

at 21:27
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesity/metabolism, and rare diseases, announced it has entered into a Clinical Trial Collaboration and...

at 19:30
Astellas Pharma Inc....



News published on and distributed by: